MucoLife Therapeutics
PrivateLast Round
Accelerator
Sep 6, 2024
Total Funding Raised
$30,000
Company Overview
MucoLife Therapeutics is a biotechnology company developing inhaled therapies for pulmonary mucus obstruction in chronic lung diseases such as COPD and cystic fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MucoLife Therapeutics Comparables
Compare MucoLife Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CILA Therapeutics | 88% | |
| Aer Therapeutics | 79% | |
| Synedgen, Inc. | 79% | |
MucoLife Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 6, 2024 |
Key People
Founding team and executive leadership
MucoLife Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 6, 2024
$30K round led by Health Wildcatters
MucoLife Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MucoLife Therapeutics's valuation, stock price, and market status.